Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis

Blood

Volumn 99, Issue 1, 2002, Pages 381-383

  Beham Schmid, Christine ^a   Apfelbeck, Ute ^b   Sill, Heinz ^b   Tsybrovsky, Oleksiy ^b   Höfler, Gerald ^b   Haas, Oskar A ^b   Linkesch, Werner ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; HYDROXYUREA; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; FOLLOW UP; GRANULOPOIESIS; HUMAN; MALE; MEGAKARYOPOIESIS; MONOTHERAPY; MORPHOMETRICS; MYELOFIBROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME;

EID: 0036090225     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.381     Document Type: Article

References (19)

1. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining
2. Targeted therapies for the myeloid leukaemias
3. Efficacy and safety of a specific inhibitor to the BCR-ABL tyrosine kinase in chronic myeloid leukemia
4. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
5. Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia
6. Anti-fibrogenic effect of the tyrosine kinase inhibitor STI-571 on bone marrow fibrosis in chronic myeloid leukemia [abstract]
7. Morphologic findings in peripheral blood and bone marrow of STI571-treated chronic myelogenous leukemia patients
8. Characteristics of accelerated disease in chronic myelogenous leukemia
9. Bone marrow trephine biopsy in lymphoproliferative disease
10. Quantification of bone marrow reticulin: A normal range
11. Thrombocytosis in chronic granulocytic leukemia: Incidence and clinical significance
12. Myelofibrosis in chronic granulocytic leukaemia: Clinicopathologic correlations and prognostic significance
13. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: A comparative retrospective multicentre histological and clinical study
14. Identification of PDGF receptors on human megakaryocytes and megakaryocytic cell lines
15. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
16. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic phase Ph(1+) chronic myelogenous leukemia: A multicenter trial